As Russia weathers a fourth surge of COVID-19 cases, the country’s management of the public health challenge has yet to improve. What factors led the country here, and what does this mean for the Putin regime and the Russian people going forward?

Civil society groups are simultaneously responding to the pandemic’s direct impacts and looking to a post-pandemic future. Many economic, political, and geostrategic challenges are shaping their thinking and their strategies.

Efforts are being made to ramp up production of COVID-19 vaccines in Africa to address the continent’s low rate of vaccination. As of September 2021, there are at least twelve COVID-19 production facilities set up or in the pipeline across six African countries.

As Indonesia reels under staggering rates of COVID-19, an ambitious mass inoculation drive offers hope. But limited access to effective vaccines is trapping the Asian giant in an impossible choice between saving lives and livelihoods.

Russian scientists rolled out the country’s COVID-19 vaccine last summer, beating Western vaccine producers to the finish line. But scarce data, broken promises, and corruption have led the vaccine to lose its luster.

The United States and many other countries have rushed to send aid to India as the country battles the coronavirus pandemic. But U.S. President Joe Biden needs to focus his administration’s attention on unblocking the congested vaccine supply chain further downstream.

India has suffered a devastating new wave of infection from the coronavirus pandemic. As the country races to vaccinate its huge population, what challenges does it face?

The COVID-19 crisis in India is devastating. The Biden administration must consider exceptions to the Defense Production Act and ease the global vaccine supply chain.

This episode looks at the domestic and international reception of Russia’s Sputnik V vaccine.

The world needs to take decisive action to ensure that COVID-19 vaccine stockpiling in wealthy countries does not leave Africans without the doses they need.

After the undignified scramble for protective equipment in the pandemic’s early stages, the EU’s collective approach to coronavirus vaccines was the right strategy—even if avoidable mistakes were made.

In an interview, Salim Adib discusses Lebanon’s management of Covid-19, and expresses some hope for the future.